Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Tianfu (06868.HK) spent 23,000 Hong Kong dollars on May 14 to repurchase 7,000 shares.
14/05/2025
"Wisdom Financial APP News, Tianfu (06868.HK) announced that it will spend 23,000 Hong Kong dollars to repurchase 7,000 shares on May 14, 2025."
Latest
1 m ago
Raymond James: Maintains Allogene Therapeutics (ALLO.US) rating from Outperform to Strong Buy, with a target price changed from $10.00 to $9.00.
1 m ago
Bank of America: Maintains UnitedHealth Group (UNH.US) rating, adjusting from buy to hold rating, with a target price adjustment from $677.00 to $351.00.
2 m ago
Neuralink: The PRIME trial in the UAE explores how patients with movement and speech disorders can use thought-controlled devices for communication.
2 m ago
Uber and Volkswagen will launch autonomous driving services in Los Angeles, USA in early 2026.
2 m ago
Market news: Elon Musk's brain-machine interface company Neuralink has launched the first clinical trial in the Middle East region at a clinic in Abu Dhabi's Cleveland.
See all latest